Cerecor is a biopharmaceutical company that specializes in the development and commercialization of treatments for rare and orphan diseases. With a focus on advancing its clinical-stage pipeline, the company's innovative therapies aim to address unmet patient needs within this space. Cerecor's rare disease pipeline includes promising therapies for inherited metabolic disorders, such as congenital disorders of glycosylation, with the company having received Rare Pediatric Disease Designation and Orphan Drug Designation from the FDA. Additionally, Cerecor is working on the development of CERC-002, CERC-006, and CERC-007.
Cerecor Inc.'s ticker is CERC
The company's shares trade on the NASDAQ stock exchange
They are based in Rockville, Maryland
There are 11-50 employees working at Cerecor Inc.
It is https://www.cerecor.com/
Cerecor Inc. is in the Healthcare sector
Cerecor Inc. is in the Biotechnology industry
The following five companies are Cerecor Inc.'s industry peers: